Vittorio Ruggero Zilioli

机构：Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Fondazione Intergruppo Italiano Linfomi Onlus · ORCID：0000-0001-6915-2246

发表论文 142 篇 · 总被引 1451 次 · h-index 21

代表论文

• Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study (2025 · The Lancet Haematology · 被引 6)
• Comparative Effectiveness of R‐miniCOMP Versus R‐miniCHOP in Older Non‐Fit Patients With Diffuse Large B‐Cell Lymphoma: Insights From a “Fondazione Italiana Linfomi” Cohort Study (2025 · Hematological Oncology · 被引 5)
• Long‐term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients (2025 · HemaSphere · 被引 4)
• Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial (2025 · Blood · 被引 3)
• Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD (2025 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 3)
• Early progression beyond first‐line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study (2024 · HemaSphere · 被引 3)